News about Biotechnology, Pharmaceutical and Healthcare

12:50 EDT 21st March 2018 | BioPortfolio

Latest news articles in the life-science, healthcare, medical device, biotechnology and pharmaceuticals sectors. 

Showing News Articles 1–25 of 11,000+

Wednesday 21st March 2018

Scarcity of Actionable Oncogenes Should Not Preclude Testing

Although much remains unknown about many mutations and test results rarely clarify the need for any particular response, panel testing has already demonstrated its cost value, which continues to increase every day.

Unlocking the Potential of Immunotherapy in Breast Cancer

A pair of trials that used checkpoint inhibitors as monotherapy reported lackluster overall response rates in breast cancer.

Starting with Mother Nature’s designs will speed up critical development of new antibiotics

The post Starting with Mother Nature’s designs will speed up critical development of new antibiotics appeared first on SynBioBeta.

Research Challenges Use Of Off-Label Drug To Treat Osteoarthritis

ArticleAn off-label drug prescribed to treat osteoarthritis of the hand when conventional medication has failed is ineffective, according to new research.

In The Spotlight: G1 Therapeutics

Shares of G1 Therapeutics Inc. (GTHX) have returned an impressive 103% year-to-date while the iShares NASDAQ Biotechnology Index (ETF)(IBB) is up a paltry 2.8% during the same period.

Brufsky Discusses Biosimilar Breakthroughs and Challenges

Adam Brufsky, MD, PhD, comments the FDA approval of MYL-1401O and discusses the adoption of biosimilars in oncology.

Mylan Launches Generic Mutamycin Injection, Adds To Growing Oncology Portfolio

NewsMylan's injectables portfolio is one of the largest and most diversified in the industry, with approximately 80 injectable products in the U.S. across several therapeutic areas, and it's getting bigger.

Independent committee report seeks Brexit healthcare clarity

An independent report, entitled Brexit – Medicines, Medical Devices and Substances of Human Origin and written by the Health and Social Care Committee, has called for greater clarity regarding the future for medicine access post-Brexit. The committee puts forward that this should be one of the major issues in negotiations, given that the health of the entire UK populations rests on the outcome o...

NICE turns down Dompe's eye drops for rare eye condition over price concerns

NICE has announced that it has recommended against the use of Dompe’s recombinant human nerve growth factor eye drop therapy cenegermin on the NHS for the treatment of the rare eye condition neurotrophic keratitis. The UK watchdog cited concerns over its cost-effectiveness in its decision to reject the drug, noting that its £14,500 price tag per eight weeks of treatment would come in above its ...

One Network Using Blockchain To Secure Medical Supply Chain And Combat Counterfeit Drugs

NewsImperial Logistics leverages the cloud solution to manage the entire distribution process and help ensure the delivery of clean drugs to patients.

Regeneron's Diabetic Retinopathy Injection Garners Topline Positive Results

NewsThe Eylea (aflibercept) Injection met its 24-week Phase 3 primary endpoint in moderately severe to severe non-proliferative diabetic retinopathy. The company expects U.S. regulatory submission for diabetic retinopathy later this year.

Grand River Aseptic Manufacturing Purchases Land In Grand Rapids

NewsThe company has signed purchase agreements to acquire land in Grand Rapids, Michigan, to add to its growing presence in life sciences, expand its manufacturing capacity, and serve its growing customer base.

Takeda completes construction of new global headquarters in Tokyo

Japan’s biggest pharmaceutical firm Takeda has announced the completion of construction of its new global headquarters in the country’s capital of Tokyo, named inventively as “Takeda Global Headquarters”. The completion of the development, which was conducted as part of the “Nihonbashi-honcho 2nd District Project”, was marked by a ceremony attended by Christophe Weber, President and CE...

Domain Therapeutics Grants Bristol-Myers Squibb Non-Exclusive License for G protein-Coupled Receptor bioSens-All™ Technology

Technology provides access to new generation of sensitive biosensors to enhance drug discovery. Domain Therapeutics, a France- and Quebec-based biopharmaceutical company that specializes in the research and development of new drug candidates that target transmembrane receptors, announces the signing of a licensing agreement for its bioSens-All™ technology with Bristol-Myers Squibb, a global ...

Okayama University Research: Iron Removal as a Potential Cancer Therapy

Researchers at Okayama University report in Oncotarget a promising method for targeting cancer stem cells that cause tumor growth and cancer relapse. The approach involves administering molecules that capture iron, an overload of which is known to be a potential cause of cancer. Cancer stem cells (CSCs) are similar to normal stem cells in that they can differentiate — become cells of a ...

J&J’s longest-standing CFO finally steps down

Johnson & Johnson have revealed that its Chief Financial Officer and Executive Vice President, Dominic J. Caruso, will retire from his position in September of this year. Caruso spent close to 12 years in his position as CFO of the pharma giant and was the longest serving in this position during the company’s 132-year history. read more

Celgene bucks trend to strengthen neuroscience pipeline

Celgene has gone against industry movement to back out of the neuroscience area by putting down a potential $2.2 billion to gain options on three drug candidates held by Prothena. The deal sees Celgene pay $100 million up front, alongside buying $50 million in shares of Prothena, with milestone payments on the three drugs potentially racking up to a total payment of $2.2 billion. Whether Prothena ...

Be your own data scientist — it’s easier than you think

The post Be your own data scientist — it’s easier than you think appeared first on SynBioBeta.

Creative Diagnostics Introduces Polymer Particles for Researchers

With years of experience in the pharmaceutical and life sciences sector, Creative Diagnostics launches a large selection of high quality Polymer Particles with multiple sizes from 20 nm to 100 µm. Now its DiagPoly™ spherical polymer particles are available with plain, functional or biomolecules conjugated surfaces. These polymer particles are suitable for a broad of applications i...

FDA Nod For SGEN's Adcetris, Antibe Soars On GI Data, CHMA Empowered

Today's Daily Dose brings you news about Antibe's safety study results of ATB-346; Immunovaccine's upcoming clinical trial catalysts; Chiasma's progress in the development of octreotide capsules in the treatment of acromegaly; KemPharm's pharmacokinetic study with a KP415/d-methylphenidate in ADHD and NovaBay's strong financial performance.

Tuesday 20th March 2018

SLS To Report Data In 1H18, AVGR Slumps As Revenue Drops, DXR Down 45% In 3 Days

The following are some of the stocks that lost the largest percentage in price today in the pharma/biotech sector.

Stream Bio presents at launch of UK’s National Formulation Centre alongside industry leaders

Stream Bio Ltd, a company that develops and manufactures revolutionary bioimaging products and molecular probes, today presented its revolutionary Conjugated Polymer Nanoparticle (CPN) technology at the opening of the Centre for Process Innovation’s (CPI) National Formulation Centre. The official opening of the centre included tours of the new facilities, networking opportunities for both in...

ZEAL Displays Vigor, MDWD Getting Healed, VERU Up 80% YTD

CASI Pharmaceuticals Inc. (CASI) gained 21.81% on Tuesday, following a $50 million private placement. The financing was led by ETP Global Fund LP, IDG-Accel China Growth Fund III, and Robert W. Duggan, former Chairman and CEO of Pharmacyclics Inc., and is expected to close on or about March 21, 2018.

Guernsey could become first place in British Isles to have a suicide clinic with vote on assisted dying laws – could become first place in British Isles to have a suicide clinic with vote on assisted dying could become the first place in the British Isles to have a suicide clinic under proposals being put to a vote on the island in May. If pushed through by politicians, it would likely trigger an 18-month consultation period to pull together a ...Voice of...

Pure’s charity quiz in Ipswich raises over £2000 for mental health charity Suffolk Mind – Cambridge Network

Cambridge NetworkPure's charity quiz in Ipswich raises over £2000 for mental health charity Suffolk MindCambridge NetworkProfessional recruitment specialists Pure hosted its annual Ipswich charity quiz night last week, bringing local businesses and clients together for a battle of the brains which raised over £2,000 for mental health charity Suffolk Mind. The fun evening ...and more

Quick Search